Hemenway Trust Hemenway Trust’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $668K | Sell |
1,189
-100
| -8% | -$64.1K | 0.05% | 76 |
|
|
2025
Q4 | $872K | Sell |
1,289
-25
| -2% | -$17K | 0.07% | 67 |
|
|
2025
Q3 | $840K | Sell |
1,314
-55
| -4% | -$33.4K | 0.06% | 68 |
|
|
2025
Q2 | $734K | Sell |
1,369
-4
| -0.3% | -$1.91K | 0.06% | 75 |
|
|
2025
Q1 | $577K | Sell |
1,373
-153
| -10% | -$66.4K | 0.05% | 79 |
|
|
2024
Q4 | $631K | Sell |
1,526
-126
| -8% | -$55.3K | 0.05% | 75 |
|
|
2024
Q3 | $835K | Sell |
1,652
-100
| -6% | -$48.6K | 0.07% | 71 |
|
|
2024
Q2 | $854K | Sell |
1,752
-75
| -4% | -$37.7K | 0.07% | 70 |
|
|
2024
Q1 | $986K | Sell |
1,827
-57
| -3% | -$31.1K | 0.09% | 63 |
|
|
2023
Q4 | $1.05M | Sell |
1,884
-75
| -4% | -$35.2K | 0.1% | 61 |
|
|
2023
Q3 | $857K | Sell |
1,959
-167
| -8% | -$83.3K | 0.09% | 71 |
|
|
2023
Q2 | $1.07M | Sell |
2,126
-101
| -5% | -$48.4K | 0.1% | 65 |
|
|
2023
Q1 | $1.11M | Sell |
2,227
-358
| -14% | -$171K | 0.12% | 65 |
|
|
2022
Q4 | $1.05M | Hold |
2,585
| – | – | 0.12% | 70 |
|
|
2022
Q3 | $842K | Sell |
2,585
-20
| -0.8% | -$7.35K | 0.1% | 74 |
|
|
2022
Q2 | $914K | Sell |
2,605
-163
| -6% | -$66.5K | 0.1% | 68 |
|
|
2022
Q1 | $1.51M | Sell |
2,768
-135
| -5% | -$71K | 0.15% | 61 |
|
|
2021
Q4 | $1.91M | Sell |
2,903
-40
| -1% | -$25.1K | 0.17% | 54 |
|
|
2021
Q3 | $1.83M | Sell |
2,943
-508
| -15% | -$341K | 0.18% | 54 |
|
|
2021
Q2 | $2.18M | Sell |
3,451
-414
| -11% | -$229K | 0.22% | 50 |
|
|
2021
Q1 | $1.89M | Sell |
3,865
-508
| -12% | -$255K | 0.21% | 55 |
|
|
2020
Q4 | $2.19M | Sell |
4,373
-297
| -6% | -$133K | 0.25% | 52 |
|
|
2020
Q3 | $1.84M | Sell |
4,670
-132
| -3% | -$48.8K | 0.24% | 52 |
|
|
2020
Q2 | $1.58M | Sell |
4,802
-130
| -3% | -$37.6K | 0.22% | 55 |
|
|
2020
Q1 | $1.2M | Sell |
4,932
-25
| -0.5% | -$6.52K | 0.2% | 59 |
|
|
2019
Q4 | $1.29M | Hold |
4,957
| – | – | 0.19% | 61 |
|
|
2019
Q3 | $1.35M | Sell |
4,957
-895
| -15% | -$249K | 0.21% | 59 |
|
|
2019
Q2 | $1.61M | Sell |
5,852
-235
| -4% | -$57.9K | 0.25% | 57 |
|
|
2019
Q1 | $1.36M | Sell |
6,087
-615
| -9% | -$127K | 0.22% | 59 |
|
|
2018
Q4 | $1.25M | Sell |
6,702
-2,055
| -23% | -$421K | 0.25% | 55 |
|
|
2018
Q3 | $2.19M | Sell |
8,757
-370
| -4% | -$89.8K | 0.37% | 50 |
|
|
2018
Q2 | $1.99M | Sell |
9,127
-97
| -1% | -$20K | 0.37% | 52 |
|
|
2018
Q1 | $1.76M | Sell |
9,224
-200
| -2% | -$36.9K | 0.34% | 55 |
|
|
2017
Q4 | $1.47M | Buy |
9,424
+1,900
| +25% | +$299K | 0.28% | 56 |
|
|
2017
Q3 | $1.17M | Sell |
7,524
-100
| -1% | -$15.8K | 0.24% | 55 |
|
|
2017
Q2 | $1.23M | Sell |
7,624
-2,991
| -28% | -$486K | 0.27% | 57 |
|
|
2017
Q1 | $1.64M | Sell |
10,615
-111
| -1% | -$15.3K | 0.38% | 53 |
|
|
2016
Q4 | $1.26M | Sell |
10,726
-2
| -0% | -$228 | 0.32% | 59 |
|
|
2016
Q3 | $1.21M | Hold |
10,728
| – | – | 0.3% | 60 |
|
|
2016
Q2 | $996K | Hold |
10,728
| – | – | 0.26% | 64 |
|
|
2016
Q1 | $840K | Buy |
10,728
+6,438
| +150% | +$464K | 0.23% | 66 |
|
|
2015
Q4 | $313K | Sell |
4,290
-1,838
| -30% | -$131K | 0.08% | 117 |
|
|
2015
Q3 | $455K | Hold |
6,128
| – | – | 0.13% | 101 |
|
|
2015
Q2 | $393K | Sell |
6,128
-230
| -4% | -$15.9K | 0.1% | 120 |
|
|
2015
Q1 | $491K | Buy |
+6,358
| New | +$495K | 0.13% | 107 |
|
Other funds holding IDXX
VCM
VPM
Hemenway Trust Hemenway Trust's IDXX Position: Q1 2026 in Review
Hemenway Trust Hemenway Trust reduced its Idexx Laboratories (IDXX) stake by 7.8% in Q1 2026, selling an estimated $64.1K and leaving 1,189 shares worth $668K. The position accounts for 0.05% of the portfolio, ranked #76.
Hemenway Trust Hemenway Trust first reported a position in IDXX in Q1 2015 and has held it in 45 quarters since. The position peaked at $2.19M in Q4 2020. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.
- Hemenway Trust Hemenway Trust held 1,189 shares of Idexx Laboratories worth $668K as of Q1 2026.
- Hemenway Trust Hemenway Trust sold 100 Idexx Laboratories shares in Q1 2026, an estimated $64.1K.
- Idexx Laboratories made up 0.05% of Hemenway Trust Hemenway Trust's portfolio in Q1 2026, its #76 holding.
- Hemenway Trust Hemenway Trust first reported a position in Idexx Laboratories in Q1 2015 and has held it in 45 quarters since.
- Hemenway Trust Hemenway Trust's Idexx Laboratories position peaked at $2.19M in Q4 2020.
- 1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.
Based on Hemenway Trust Hemenway Trust's 13F filing for Q1 2026, filed 7 May 2026.